10.1002/cbdv.202000763
Chemistry & Biodiversity
Chem. Biodiversity
In summary, we have synthesized a series of thirty-one sarisan attached 3-phenylisoxazolines IV1–31, and determined their structures by different spectral
analyses of 1H/13C NMR, IR and ESI-MS. All title sarisan attached 3-phenylisoxazolines IV1–31 were evaluated for their antifungal activities against five
phytopathogenic fungi (B. cinerea, C. lagenarium, A. solani, F. solani, and F. graminearum). Among all title sarisan derivatives, compounds IV2, IV14 and
IV23 showed more promising antifungal activity against some phytopathogenic fungi than the commercial fungicide Hymexazol. In particular, compound
IV2 exhibited a broad-spectrum and potent antifungal activity against three phytopathogenic fungi (A. solani, F. solani, and F. graminearum) with the EC50
values of 32.9 ± 1.6, 35.6 ± 0.3, and 33.4 ± 0.4 μg/mL, respectively. In addition, compounds IV2, IV14 and IV23 also displayed relative low toxicity on normal
NRK-52E cells. These resluts indicated that the potent sarisan attached 3-phenylisoxazolines IV2, IV14 and IV23 had selectivity between phytopathogenic
fungi and normal mammalian cells. This work will pave the way for the development of sarisan derivatives as fungicide candidates in plant protection.
Experimental Section
Instruments and Reagents
1H NMR/13C NMR spectra of all sarisan derivatives IV1–31 were recorded on a Bruker 400/100 MHz instrument (Avance 400 MHz, Bremerhaven, Germany).
Infrared (IR) spectra were detected by a PE-1710 FT-IR spectrometer. A Microplate Reader (Tecan Infinite Pro series M200) was used to record optical density
and fluorescence. Sesamol was purchased from Aladdin Bio-Chem Technology Co., Ltd. (Shanghai, China). Anhydrous solvents were dried and purified
according to standard methods before use. Other chemicals were of analytical grade and all obtained from commercial resources.
Synthesis of Sarisan Attached 3-Phenylisoxazolines IV1–31
Sarisan and the intermediates N-hydroxybenzimidoyl chlorides III1–31 were prepared as our previously reported procedures.[24, 25] Then, to a solution of
sarisan (0.5 mmol, 96.1 mg) in CH2Cl2 (10 mL) under N2, the corresponding N-hydroxybenzimidoyl chlorides III1–31 (0.55 mmol) and trimethylamine (0.55
mmol, 55.7 mg) were added. The mixture was stirred for 6–24 h at room temperature (r.t.). When the reaction was complete, the solvent was concentrated
and then purified by PTLC with developing solvents petroleum ether: ethyl acetate = 3: 1 (v/v) to give the target derivatives IV1–31 in 21–81% yields.
Examples of spectra data of IV1–3 are shown below, whereas data of other derivatives IV4–31 are listed in Supporting Information.
1
Data for IV1: Gray solid, yield: 81%, m.p. 90-92oC; IR cm-1 (KBr): 2916, 1621, 1487, 1354, 1290, 1196, 1031, 923, 845, 757, 690; H NMR (400 MHz CDCl3) δ:
7.65-7.62 (m, 2H, -Ar), 7.39-7.38 (m, 3H, -Ar), 6.72 (s, 1H, -Ar), 6.52 (s, 1H, -Ar), 5.90 (s, 2H, -OCH2O-), 5.01-4.94 (m, 1H, H-5′), 3.76 (s, 3H, -OCH3), 3.30-3.23
(m, 1H, H-4′), 3.09-3.05 (m, 1H, H-6′), 3.03-3.00 (m, 1H, H-4′), 2.85-2.80 (m, 1H, H-6′); 13C NMR (100 MHz CDCl3) δ: 156.5, 152.5, 146.9, 140.9, 129.9, 128.6,
126.6, 110.9, 101.0, 94.6, 80.9, 56.2, 39.2, 35.2, 35.3; MS (ESI) m/z calcd for C18H18NO4 ([M+H]+) 312.1, found 312.1.
1
Data for IV2: Yellow solid, yield: 38%, m.p. 52-54oC; IR cm-1 (KBr): 2924, 1596, 1488, 1456, 1195, 1036, 931, 761; H NMR (400 MHz CDCl3) δ: 7.84-7.80 (m,
1H, -Ar), 7.39-7.33 (m, 1H, -Ar), 7.17-7.13 (m, 1H, -Ar), 7.11-7.06 (m, 1H, -Ar), 6.72 (s, 1H, -Ar), 6.51 (s, 1H, -Ar), 5.89 (s, 2H, -OCH2O-), 5.00-4.93 (m, 1H, H-5′),
3.76 (s, 3H, -OCH3), 3.39-3.32 (m, 1H, H-4′), 3.19-3.13 (m, 1H, H-6′), 3.02-2.97 (m, 1H, H-4′), 2.86-2.81 (m, 1H, H-6′); 13C NMR (100 MHz CDCl3) δ: 161.5, 159.0,
153.3, 152.5, 146.9, 140.9, 131.4, 129.0, 124.3, 117.9, 117.2, 116.4, 116.2, 110.9, 101.0, 94.5, 81.1, 56.2, 41.0, 35.2; MS (ESI) m/z calcd for C18H17FNO4 ([M+H]+)
330.1, found 330.3.
1
Data for IV3: Gray solid, yield: 24%, m.p. 121-123oC; IR cm-1 (KBr): 2936, 1622, 1498, 1486, 1196, 1035, 927, 852, 763; H NMR (400 MHz CDCl3) δ: 7.59-7.56
(m, 1H, -Ar), 7.41-7.39 (m, 1H, -Ar), 7.34-7.27 (m, 2H, -Ar), 6.74 (s, 1H, -Ar), 6.51 (s, 1H, -Ar), 5.90 (s, 2H, -OCH2O-), 5.04-4.96 (m, 1H, H-5′), 3.76 (s, 3H, -OCH3),
3.45-3.38 (m, 1H, H-4′), 3.25-3.19 (m, 1H, H-6′), 3.05-3.00 (m, 1H, H-4′), 2.88-2.83 (m, 1H, H-6′); 13C NMR (100 MHz CDCl3) δ: 156.5, 152.2, 146.9, 140.9, 132.8,
130.4, 129.5, 126.9, 117.1, 111.0, 101.0, 94.5, 81.5, 56.2, 41.7, 35.0; MS (ESI) m/z calcd for C18H1735ClNO4 ([M+H]+) 346.0, found 346.1, C18H1737ClNO4 ([M+H]+)
348.0, found 348.1.
Antifungal and Cytotoxic Activities
The antifungal activity of all title sarisan attached 3-phenylisoxazolines IV1–31 against five phytopathogenic fungi was evaluated by using the mycelium
growth rate method according to our previous report.[21] PDA medium was prepared through using potato dextrose agar and then sterilized at 115 °C for 30
min. Each fungus was incubated in PDA at 28 ± 1 °C for about 5 days to get new mycelium for the antifungal assays, and then using a sterilized puncher to
cut a mycelia disk of approximately 5 mm diameter from culture medium. Subsequently, the mycelia disk was inoculated in the center of the PDA Petri
dishes. The tested derivatives IV1–31 and Hymexazol were dissolved in acetone, then mixed with the medium to set at the final concentration of 50 μg/mL.
The mixed medium was then added to the sterilized Petri dishes. The inoculated Petri dishes were incubated at 28±1 °C for 3 days. Acetone with only PDA
was served as a blank control (CK); the commercial fungicide Hymexazol was used as the positive control. Each treatment was conducted with three
5
This article is protected by copyright. All rights reserved.